MetaVia's DA-1726: Promising Weight Loss Solution With Strong Buy Potential Despite Market Overreaction

TipRanksApr 17 10:35 ET

MetaVia Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

Dow JonesApr 16 07:58 ET · Ratings

Promising Clinical Trial Results for MetaVia's DA-1726: A Potential Leading Weight Loss Therapy

TipRanksApr 16 06:27 ET

MetaVia Reports 'Positive' Results for Obesity Treatment in Part 2 of Phase 1 Trial

MT NewswiresApr 15 12:16 ET

Express News | Metavia Shares up 6.5% After Its Experimental Obesity Drug Shows Promise in Early-Stage Study

ReutersApr 15 09:31 ET

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

BenzingaApr 15 08:08 ET